OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA
Clinical trials for OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a pneumonia drug beat back resistant ovarian cancer?
Disease control Recruiting nowThis study tests whether atovaquone, a drug normally used for infections, can help people with a type of ovarian cancer that no longer responds to standard platinum chemotherapy. About 28 adults with platinum-resistant high-grade serous ovarian cancer will take atovaquone. The go…
Matched conditions: OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 06:05 UTC
-
New drug combo targets Hard-to-Treat ovarian and endometrial cancers
Disease control Recruiting nowThis early-phase study tests two experimental drugs (M1774 and ZEN-3694) together in people whose ovarian or endometrial cancer has returned. The goal is to find the safest dose and see how well the combination works. About 65 participants will take part to help determine if this…
Matched conditions: OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Shorter treatment may be just as effective for ovarian cancer patients
Disease control Recruiting nowThis study looks at whether taking the drug olaparib for one year is as good as taking it for two years to keep ovarian cancer from coming back. It includes people with advanced ovarian cancer who have certain gene changes (BRCA or HRD). The goal is to find the best treatment len…
Matched conditions: OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 19, 2026 11:59 UTC